These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35842415)

  • 21. Platelet proteome reveals novel pathways of platelet activation and platelet-mediated immunoregulation in dengue.
    Trugilho MRO; Hottz ED; Brunoro GVF; Teixeira-Ferreira A; Carvalho PC; Salazar GA; Zimmerman GA; Bozza FA; Bozza PT; Perales J
    PLoS Pathog; 2017 May; 13(5):e1006385. PubMed ID: 28542641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi.
    Lopuhaä BV; Guzel C; van der Lee A; van den Bosch TPP; van Kemenade FJ; Huisman MV; Kruip MJHA; Luider TM; von der Thüsen JH
    Histopathology; 2024 May; 84(6):967-982. PubMed ID: 38253958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.
    Li N; Zhao L; Zhan X
    J Cell Physiol; 2021 Apr; 236(4):2959-2975. PubMed ID: 32959892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Omicron variant infection affects blood platelets, a comparative analysis with Delta variant.
    Garcia C; Compagnon B; Ribes A; Voisin S; Vardon-Bounes F; Payrastre B
    Front Immunol; 2023; 14():1231576. PubMed ID: 37828997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
    Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
    Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.
    Zhang Y; Shang L; Zhang J; Liu Y; Jin C; Zhao Y; Lei X; Wang W; Xiao X; Zhang X; Liu Y; Liu L; Zhuang MW; Mi Q; Tian C; Wang J; He F; Wang PH; Wang J
    Cell Chem Biol; 2022 Jan; 29(1):5-18.e6. PubMed ID: 34672954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets and COVID-19.
    Rohlfing AK; Rath D; Geisler T; Gawaz M
    Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of stimulated platelets in COVID-19 thrombosis: Role of alpha7 nicotinic acetylcholine receptor.
    Jankauskaite L; Malinauskas M; Snipaitiene A
    Front Cardiovasc Med; 2022; 9():1037369. PubMed ID: 36312286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Proteomic Analysis for New Types of Long-Term Persistent COVID-19 Patients in Wuhan.
    Li C; Yue L; Ju Y; Wang J; Chen M; Lu H; Liu S; Liu T; Wang J; Hu X; Tuohetaerbaike B; Wen H; Zhang W; Xu S; Jiang C; Chen F
    Microbiol Spectr; 2022 Dec; 10(6):e0127022. PubMed ID: 36314975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
    Zhang H; Zheng H; Zhu J; Dong Q; Wang J; Fan H; Chen Y; Zhang X; Han X; Li Q; Lu J; Tong Y; Chen Z
    J Proteome Res; 2021 May; 20(5):2224-2239. PubMed ID: 33666082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
    Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
    Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype.
    Bongiovanni D; Klug M; Lazareva O; Weidlich S; Biasi M; Ursu S; Warth S; Buske C; Lukas M; Spinner CD; Scheidt MV; Condorelli G; Baumbach J; Laugwitz KL; List M; Bernlochner I
    Cell Death Dis; 2021 Jan; 12(1):50. PubMed ID: 33414384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets?
    Campbell RA; Boilard E; Rondina MT
    J Thromb Haemost; 2021 Jan; 19(1):46-50. PubMed ID: 33119197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
    Gordon DE; Jang GM; Bouhaddou M; Xu J; Obernier K; White KM; O'Meara MJ; Rezelj VV; Guo JZ; Swaney DL; Tummino TA; Hüttenhain R; Kaake RM; Richards AL; Tutuncuoglu B; Foussard H; Batra J; Haas K; Modak M; Kim M; Haas P; Polacco BJ; Braberg H; Fabius JM; Eckhardt M; Soucheray M; Bennett MJ; Cakir M; McGregor MJ; Li Q; Meyer B; Roesch F; Vallet T; Mac Kain A; Miorin L; Moreno E; Naing ZZC; Zhou Y; Peng S; Shi Y; Zhang Z; Shen W; Kirby IT; Melnyk JE; Chorba JS; Lou K; Dai SA; Barrio-Hernandez I; Memon D; Hernandez-Armenta C; Lyu J; Mathy CJP; Perica T; Pilla KB; Ganesan SJ; Saltzberg DJ; Rakesh R; Liu X; Rosenthal SB; Calviello L; Venkataramanan S; Liboy-Lugo J; Lin Y; Huang XP; Liu Y; Wankowicz SA; Bohn M; Safari M; Ugur FS; Koh C; Savar NS; Tran QD; Shengjuler D; Fletcher SJ; O'Neal MC; Cai Y; Chang JCJ; Broadhurst DJ; Klippsten S; Sharp PP; Wenzell NA; Kuzuoglu-Ozturk D; Wang HY; Trenker R; Young JM; Cavero DA; Hiatt J; Roth TL; Rathore U; Subramanian A; Noack J; Hubert M; Stroud RM; Frankel AD; Rosenberg OS; Verba KA; Agard DA; Ott M; Emerman M; Jura N; von Zastrow M; Verdin E; Ashworth A; Schwartz O; d'Enfert C; Mukherjee S; Jacobson M; Malik HS; Fujimori DG; Ideker T; Craik CS; Floor SN; Fraser JS; Gross JD; Sali A; Roth BL; Ruggero D; Taunton J; Kortemme T; Beltrao P; Vignuzzi M; García-Sastre A; Shokat KM; Shoichet BK; Krogan NJ
    Nature; 2020 Jul; 583(7816):459-468. PubMed ID: 32353859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets.
    Yapasert R; Khaw-On P; Banjerdpongchai R
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946543
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.